Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT06015711
Recruiting Not applicable

The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement

NCT06015711 · tracked via the Priya Life Science South Korea tracker
Sponsor
Ajou University School of Medicine
Phase
Not applicable
Started
2023-08-30
Last updated
2025-10-03

Condition(s) studied

Opioid Use

Investigational drug(s) / intervention(s)

Maxigesic administration

Maxigesic administration: Preoperative Maxigesic IV administration

Study summary

Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.

Eligibility

Sex
ALL
Min age
19 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patients (19-60 years old) with ASA physical status 1, 2, 3 * Scheduled surgery under general anesthesia Exclusion Criteria: * The patient does not conset * Pregnancy * hepatic disorder * Renal disorder * Asthma * Hypersensitivity to the NSAIDs or acetaminophen * Patients receiving chronic pain therapy * Drug dependence * Patients taking psychiatric drugs * Alcoholics * History of gastrointestinal ulcer or bleeding

Primary outcome measure(s)

  • Remifentanil requirement — 3 hours, from incision to skin closure
    Intraoperative remifentanil requirement

Trial sites (1)

FacilityCityRegionStatus
Ajou university school of medicine Suwon Gyeonggi-do Recruiting

More Ajou University School of Medicine trials in South Korea

NAVO:J School-Based Group Intervention for Adolescent Mental Health Starting soon
Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients Active, not recruiting
Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study Recruiting
AI ECG Algorithm for Detecting LV Systolic Dysfunction Recruiting

Other trials for the same condition

Evaluation of an Opioid Stewardship Program in Non-Cancer Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06015711 on ClinicalTrials.gov ↗ ← All trials in South Korea